Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment.

نویسنده

  • Yaddanapudi Ravindranath
چکیده

Down syndrome is the most common autosomal chromosomal disorder with incidence ranging from 1 in 700 to 1:1,000 live births [1]. The protean manifestation are mental retardation, congenital heart disease, and risk for early death. The predominant cause of death is related to the congenital heart defects followed by hypothyroidism, respiratory infections, and malignancy (particularly, leukemia) [2,3]. Death from leukemia in Down syndrome children is predominately in the younger ages [2]. Down syndrome children account for approximately 3% of children with acute lymphoblastic leukemia (ALL) and 5–8% of children with acute myeloid leukemia (AML) diagnosed in the United States. Despite the fact that the association of increased risk for leukemia with Down syndrome have now been recognized for nearly 50 years, it is this relatively low frequency of the total number of cases and the reluctance to give aggressive chemotherapy in a developmentally challenged youngster hindered the systematic evaluation of the pathogenesis and treatment of leukemia in children with Down syndrome. Within the last two decades, several important developments in the understanding of the biology and treatment of leukemias in Down syndrome children have occurred. These developments in general define the pivotal role played by chromosome 21, both in childhood ALL and AML. The serendipitous discovery of the unique drug sensitivity of AML in Down syndrome [4] provided additional impetus for these studies. What emerges is a fascinating story for increased risk for leukemia on the one hand and the increased sensitivity to chemotherapy on the other [5]. In this issue of the journal, six articles describe some of these developments and provide new insights on the biology and treatment of leukemia in Down syndrome [3,6–10]. It is a privilege to write this overview. The articles will be reviewed in the context of epidemiology, pathogenesis, and treatment/drug sensitivity. Some of the remaining challenges will be identified in the summation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Insights into the autistic disorder and potential therapeutic approaches

Autism and autism spectrum disorders (ASDs) such as Rett syndrome and Asperger syndromeare enigmatic and complex neurodevelopmental disorders, thought to have originated inparticular interactions of genetic and environmental factors. Despite the extensive research,exact mechanism of pathogenesis is not still completely understood. ASDs are characterizedby deficits and abnormalities in communica...

متن کامل

DNA-Repair Capacity in Down\'s Syndrome

Down's syndrome (DS) is the most common chromosomal abnormality in human. Subjects with DS are known to be peridisposed to develop leukemia. The molecular basis of the association between DS and leukemia is unknown. The unscheduled DNA synthesis (UDS) test measure the ability of DNA-repair in mammalian cells after excision of a stretch of DNA containing the region of damage induced by chemical ...

متن کامل

MicroRNAs as a New Molecular Biomarker for Diagnosis and Prognosis of T-cell Acute Lymphoblastic Leukemia (T-ALL): A Systematic Review

MicroRNAs (miRNAs, miRs) are small endogenous non-coding RNAs that regulate the expression of protein-encoding genes at the post-transcriptional level. Several studies have described the role of miRNAs in T-cell acute lymphoblastic leukemia (T-ALL), including tumor suppressor and oncogenic miRNAs. Down-regulation of miRNA expression is a prominent feature of human malignancy. This down-regulati...

متن کامل

Genetics and epidemiology of Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)

Background and aims: Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by a coronavirus. After the primary onset of MERS in Saudi Arabia, in September 2015 cases began to increase. The number of laboratory-affirmed cases by MERS-CoV in the Middle East has been being increased recently. Methods: In this current review article, by using the terms “MERS” and “coronavir...

متن کامل

UBE2Q1, as Down Regulated Gene in Pediatric Acute Lymphoblastic Leukemia

Ubiquitin - proteasome system (UPS), the major protein degradation pathway in the cells, typically degrades short - lived and damaged proteins and regulates growth and stress responses. This pathway is altered in various cancers, including Acute Lymphoblastic Leukemia (ALL). ALL begins with a change in bone marrow cells and is the most common type of leukemia in children under 15 years. UBE2Q1...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Pediatric blood & cancer

دوره 44 1  شماره 

صفحات  -

تاریخ انتشار 2005